However, if disease-free individuals had served as controls, the observed risk estimates for the TLR3 and IRAK4 loci would have been even more extreme, since disease-free individuals would be expected to have a smaller tendency to develop BrCa than individuals with benign nodules. The gene discussed is TLR3; the disease is invasive breast carcinoma.